The medical records on all cases of pneumococcal bacteremia in adults at the University Hospital, Leiden, over a 10-year period (1976-1986) were retrospectively reviewed. In this series of 147 episodes (an annual incidence of 0.8 episodes/10,000 adults), overall mortal ity was 25.9%. Factors significantly related to a higher mortality rate were shock, respira tory insufficiency, preexisting renal failure, and rapidly fatal underlying disease. Several laboratory abnormalities -such as a low percentage of band forms, an elevated level of serum lactate dehydrogenase, and hyperbilirubinemia -were significantly related to a poor outcome. Multilobar pneumonia and meningitis were both associated w'ith high mortal ity, although not to a statistically significant degree. Discriminant analysis showed the presence of shock as the most powerful predictive factor of death. Surprisingly, prior splenectomy did not correlate with higher mortality. Treatment with p-lactam antibiotics favorably influenced the outcome of illness in patients with ultimately fatal and nonfatal underlying disease, while the use of these agents in patients w'ith rapidly fatal underlying disease did not correlate significantly with a good prognosis.
The pneumococcus (Streptococcus pneumoniae) is one of the microorganisms most pathogenic for hu mans. Despite the advent of penicillin, the pneu mococcus has remained a major cause of disease. It is the foremost cause of community-acquired pneumonia and of bacterial meningitis in the elderly [1] [2] [3] [4] . The latter infection still has a disturbingly high fatality rate.
In this paper, data are presented on the incidence of and the case-fatality rate for pneumococcal bac teremia in an adult population. These data are based on a retrospective analysis of records of patients from whose blood S. pneumoniae was isolated. The aim of this retrospective study was to discern risk fac-
Patients and Methods
The records of adult patients from whose blood S. pneumoniae was isolated between January 1976 and January 1986 at the University Hospital, Leiden (UHL), were reviewed. UHL is a 900-bed hospital in which both general health care and all specialties are covered. Patients were identified by a search for cases of pneumococcal bacteremia in the computer ized registry of the microbiology laboratory. A total of 147 episodes in 142 patients were found. The records of three patients could not be retrieved; how ever, since their age and sex and the outcome of their illness were known, their data were included in the calculation of incidence and mortality. One patient's record provided insufficient data. Thus, a total of four patients were not included in further analyses.
Blood cultures were usually performed if the pa tient had fever (i.e., a rectal temperature of >38.5°C). Isolates of S. pneumoniae were identified by stan dard laboratory techniques; isolates are not routinely typed in the Netherlands.
Episodes were categorized as community acquired (present on admission) or nosocomial (both the manifestation of illness and positive blood cultures at least 3 days after admission). Meningitis was de fined by the isolation of S. pneumoniae from CSF or the detection of pneumococcal antigen in CSF. Empyema was defined by the isolation of S. pneu moniae from pleural fluid. Endocarditis was defined by the criteria of Von Reyn et al. [5] . Arthritis was diagnosed clinically. The diagnosis of pneumonia and sinusitis was in all cases confirmed by roent genography. Pneumococcal peritonitis was defined by the isolation of S. pneumoniae from ascites. Re spiratory insufficiency was defined as a P a 0 2 of <7 kPa or a P aC 0 2 of >7 kPa. Shock was defined as systolic blood pressure less than 90 mm Hg in ad dition to other clinical signs of shock. Death was con sidered directly related to pneumococcal bacteremia when, as judged by clinical and pathologic criteria, the bacteremia was the prime cause.
The underlying disease of the patients was classi fied (according to McCabe and Jackson [6] ) as rap idly fatal, ultimately fatal, or nonfatal. Blood counts and chemical tests were assessed on the SMA-12 mul tichannel autoanalyzer (Technicon, Tarrytown, N.Y.); data obtained on the day of the positive blood cul ture or the day thereafter were used in this analysis. Antimicrobial therapy was scored with regard to the choice of antibiotic.
Statistical analysis for comparison of two groups was performed by the x2 test for dichotomous vari ables and Student's t test for continuous variables (sometimes after a logarithmic transformation). For identification of the risk factors most predictive of a poor outcome of pneumococcal bacteremia, 10 variables were studied: age, prior splenectomy, previ ous renal failure, underlying disease, chest roentgenographic abnormalities, origin of infection, menin gitis, shock, respiratory insufficiency, and antibiotic use. These variables were studied in cross-tabulations against death or survival with stepwise discriminant analysis [7] .
Results
Characteristics o f patients. Between January 1976 and January 1986, 147 episodes of pneumo coccal bacteremia were registered at UHL, for an av erage of 14.7 episodes per year. For an estimated adult adherence population (a population calcula tion used by the Dutch government for hospitals with a large number of referrals, e.g., university hospi tals) of 180,000 patients per year, the annual inci dence of pneumococcal bacteremia is ^0.8 cases/ 10,000 adults. In terms of admissions (average, 17,335 adults per year), the figures are indicative of 0.8 epi sodes/1,000 admissions.
The characteristics of the patients studied are sum marized in table 1. The mean age of the entire study ing nonfatal underlying disease included 11 patients with no known underlying illnesses.
Fifteen episodes occurred in patients who had been splenectomized; the total number of splenec tomies performed at this hospital in the 10-year period was 354. The interval between splenectomy and pneumococcal infection ranged from 3 days to 34 years. In seven of the 15 bacteremic episodes in splenectomized patients, primary bacteremia was present; i.e., no apparent portal of entry could be identified.
Complications. A wide range of complications occurred in a large number of patients. These events are summarized in table 3. Treatment. Treatment with a (3-lactam antibiotic was considered appropriate. Thus, 129 episodes were treated appropriately. In nine of 14 episodes not treated with a (3-lactam antibiotic, drugs were with held for the following reasons: clinically insignifi cant bacteremia (two cases), terminal oncologic dis ease (five), and bacteremia occurring as a fulminant lethal event (two). In the other five of these 14 epi sodes, an aminoglycoside, a sulfonamide, trimethoprim-sulfamethoxazole, or a tetracycline was given.
Outcome and analysis o f risk factors. Bacterem ic episodes ended fatally in 38 cases; with a total of 147 episodes, the overall mortality rate was 25.9%. With exclusion of the nine untreated cases, the cor rected mortality rate for treated pneumococcal bac teremia dropped to 22.5%. Analysis of the study pop ulation by decade of age showed no significantly poorer outcome for any decade. The relative number of deaths in male and female patients was also simi lar (table 1) . Of a large number of clinical features, only a low systolic blood pressure and an absence of pleuritic chest pain were significantly related to mortality rate. Laboratory data analysis showed a significant association between a low percentage of band forms in the blood smear, a high serum level of lactate dehydrogenase, and a high serum level of bilirubin on the one hand and a poor outcome on the other. As indicated in table 2, splenectomy proved not to be a significant risk factor. Rapidly fatal un derlying disease was a highly significant risk factor for poor prognosis, as was preexisting renal failure (P < .001 for both). As indicated in table 3, shock and respiratory insufficiency were the only compli cations significantly related to a poor outcome (P < .001 and P < .02, respectively). Complications proved to be additive in determining a poor outcome.
Despite the fact that all treated bacteremic epi sodes in patients with rapidly fatal underlying dis ease were treated with (3-lactam antibiotics, the fa tality rate was 60%. This outcome was significantly poorer than that for (3-lactam-treated patients with ultimately fatal or nonfatal underlying disease (P < .001). Treatment of the latter groups with (3-lactam agents resulted in mortality rates of 0 and 12%, respectively.
Stepwise discriminant analysis showed the most prognostic factors to be (in descending order) the presence of shock, the existence of rapidly fatal un derlying disease, the presence of meningitis, and the involvement of multiple lobes. Analysis of these four variables yielded 32 correct predictions of 37 fatal outcomes (87%) and 87 correct predictions of 106 nonfatal outcomes (82%).
Discussion
In this retrospective study of 147 episodes of pneu mococcal bacteremia, the case-fatality rate was 25.9% for all episodes and 22.5% of episodes treated with antibiotics. Patients with rapidly fatal under lying disease had a poor prognosis if they manifested pneumococcal bacteremia. Apart from rapidly fa tal underlying disease, a number of other risk fac tors were found, including preexisting renal failure, presence of shock, presence of respiratory insuffi ciency, absence of pleuritic chest pain, low number of band forms, and elevated serum levels of lactate dehydrogenase and bilirubin. In these respects our results are similar to those of studies from other countries during the antibiotic era [8] [9] [10] [11] [12] [13] [14] [15] [16] . As the most powerful predictive factors of a poor outcome of illness, we found first of all the presence of shock, which was followed in significance by rapidly fatal underlying disease, the presence of meningitis, and multilobar pneumonia.
Some divergence from prior studies exists, how ever. First, we did not find increased mortality with advanced age [8, 17] . A partial explanation could be that in our study many relatively young patients (under 50 years of age) had rapidly fatal underlying disease. Another factor of possible influence is that elderly patients may currently tend to seek medical attention more promptly than in previous years [18] . Second, we did not find a significantly higher mor tality among patients with nosocomial bacteremia than among those with community-acquired bacter emia; this result is in contrast to those of recent studies of veterans [19] . Third, an intriguing obser vation not previously made is that pneumococcal bacteremia occurred significantly more frequently in women than in men. However, case-fatality rates were similar for the two sexes. Fourth, mortality among splenectomized persons at UHL was only 0.6%, whereas Singer [20] , in his study of more than 2,795 splenectomized persons, reported a much higher mortality rate of 2.52%. This difference in death rate cannot be explained by a higher degree of vaccination in our group, since only one of the splenectomized persons had been vaccinated before developing pneumococcal bacteremia. One hypoth esis is that in a small country like the Netherlands these patients are able to seek medical attention at a comparatively early stage, resulting in prompt treatment.
In our series, appropriate therapy did not have an effect on the course of illness in patients who were particularly at risk -i.e., those with rapidly fatal un derlying disease. This observation confirms the im portance of underlying disease in the treatment and outcome of infections [6] . It also emphasizes the ur gent need for specific preventive measures in this high-risk group.
In conclusion, our study shows no major geo graphic differences with regard to the incidence, out come, or clinical picture of pneumococcal bacter emia. However, some points of divergence with prior studies exist; these discrepancies may be related to country size, patient population, and other factors.
